K

Kronos Bio
D

KRON

0.90140
USD
-0.05
(-5.71%)
Market Closed
Volume
3,460
EPS
0
Div Yield
0
P/E
-1
Market Cap
54,349,561
OverviewSignalsIdeasNews
Related Instruments
    ACN
    -2.48
    (-0.75%)
    328.07 USD
    ADSK
    -5.880
    (-2.38%)
    241.690 USD
    CRM
    -5.730
    (-2.21%)
    253.060 USD
    NOW
    -3.33
    (-0.41%)
    811.13 USD
    N
    NTNX
    -1.490
    (-2.95%)
    49.020 USD
    O
    OKTA
    -2.465
    (-2.63%)
    91.415 USD
    S
    SPLK
    0
    (0%)
    0.000000 USD
    TEAM
    -3.300
    (-1.87%)
    173.280 USD
    WDAY
    -4.560
    (-2.01%)
    222.590 USD
    Z
    ZS
    -4.980
    (-2.78%)
    174.400 USD
    More
News

Title: Kronos Bio

Sector: Healthcare
Industry: Biotechnology
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.